Recombinant antibody production utilizes mammalian cell lines for the generation of therapeutic antibodies. Chinese hamster ovary (CHO) cells emerged as a leading platform due to their efficiency in producing complex, humanized antibodies. High-yield growth of CHO cells is crucial for commercial success and involves meticulous optimization of vario